Login / Signup

Newborn Screening for β-Thalassemia Identifies a Complex Genotype Involving a Novel β-Globin Gene Mutation ( HBB :c.336dup).

John S WayeMeredith HannaBetty-Ann HohenadelLisa NakamuraLynda WalkerBarry EngLandry E Nfonsam
Published in: Hemoglobin (2024)
Newborn screening identified a Chinese-Canadian infant who was positive for possible β-thalassemia (β-thal). Detailed family studies demonstrated that the proband was a compound heterozygote for the Chinese G γ( A γδβ) 0 -thal deletion and a novel frameshift mutation within exon 3 ( HBB :c.336dup), and heterozygous for the Southeast Asian α-thal deletion (-- SEA /αα). This case illustrates the importance of follow-up molecular testing of positive newborn screening results to confirm the diagnosis and define risks for future pregnancies.
Keyphrases
  • early onset
  • preterm birth
  • sickle cell disease
  • current status
  • dna methylation
  • human health
  • pregnancy outcomes